Shock Index, Pediatric Age-Adjusted Predicts Morbidity and Mortality in Children Admitted to the Intensive Care Unit

Kuo-Chen Huang1, Ying Yang1, Chao-Jui Li1

  • 1Department of Emergency Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Frontiers in Pediatrics
|October 15, 2021
PubMed

Insights

The pediatric age-adjusted shock index (SIPA) can predict outcomes in non-traumatic pediatric intensive care unit (ICU) patients. An increasing SIPA within 24 hours of ICU admission indicates higher mortality and adverse events.

Area of Science:

  • Pediatric Critical Care Medicine
  • Emergency Medicine
  • Clinical Prognostic Markers

Background:

  • The pediatric age-adjusted shock index (SIPA) is a validated predictor of morbidity and mortality in pediatric trauma.
  • Its utility in non-traumatic pediatric emergency department (ED) admissions to the intensive care unit (ICU) remains less explored.

Purpose of the Study:

  • To investigate the prognostic value of SIPA in non-traumatic pediatric patients admitted directly to the ICU from the ED.
  • To determine if changes in SIPA within the first 24 hours of ICU admission correlate with patient outcomes.

Main Methods:

  • A multicenter retrospective study of 1,732 non-traumatic pediatric patients (aged 1-17 years) admitted to the ICU.
  • SIPA was calculated on ED arrival and 24 hours post-ICU admission, using age-specific cutoffs.
  • Outcomes analyzed included mortality, mechanical ventilation, inotropic support, and hospital length of stay.

Main Results:

  • An elevated SIPA at 24 hours post-admission was significantly associated with increased mortality (OR: 4.366), mechanical ventilation (OR: 1.826), inotropic support (OR: 2.306), and longer hospital stay.
  • Persistent abnormal SIPA values also predicted higher mortality, need for mechanical ventilation, inotropic support, and prolonged hospitalization.
  • A decrease from abnormal to normal SIPA correlated with reduced mortality, while a normal to abnormal shift indicated increased mortality risk.

Conclusions:

  • SIPA is a valuable early prognostic indicator for non-traumatic pediatric ICU admissions.
  • Monitoring SIPA trends within the first 24 hours of ICU admission can aid in risk stratification and guide early management strategies.
  • The findings support the use of SIPA for predicting adverse outcomes in critically ill children.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
41
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
156
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.1K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
209
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.6K